Viewing Study NCT03059693


Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2026-03-01 @ 4:45 PM
Study NCT ID: NCT03059693
Status: COMPLETED
Last Update Posted: 2017-02-23
First Post: 2017-02-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis
Sponsor: Haus Bioceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module